M THERIEN - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

M THERIEN

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 17, 2001

In vitro metabolism of the COX-2 inhibitor DFU, including a novel glutathione adduct rearomatizationJ A Yergey, L A Trimble, J Silva, et al.

Journal of Biophotonics|February 25, 2025

Hyperspectral Imaging of Uterine FibroidsAidan M Therien, Jonah A Majumder, Arielle S Joasil, et al.

Journal of Medicinal Chemistry|April 3, 1992

Development of 2,3-dihydro-6-(3-phenoxypropyl)-2-(2-phenylethyl)-5-benzofuranol (L-670,630) as a potent and orally active inhibitor of 5-lipoxygenaseC K Lau, P C Bélanger, C Dufresne, et al.

Pageof 2

Search research articles

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 17, 2001

In vitro metabolism of the COX-2 inhibitor DFU, including a novel glutathione adduct rearomatizationJ A Yergey, L A Trimble, J Silva, et al.

Journal of Biophotonics|February 25, 2025

Hyperspectral Imaging of Uterine FibroidsAidan M Therien, Jonah A Majumder, Arielle S Joasil, et al.

Journal of Medicinal Chemistry|April 3, 1992

Development of 2,3-dihydro-6-(3-phenoxypropyl)-2-(2-phenylethyl)-5-benzofuranol (L-670,630) as a potent and orally active inhibitor of 5-lipoxygenaseC K Lau, P C Bélanger, C Dufresne, et al.

Pageof 2